Javascript must be enabled to continue!
THE PLACE OF CARDIAC COMPUTED TOMOGRAPHY IN PREOPERATIVE PLANNING OF EXTENDED SEPTAL MYECTOMY IN PATIENTS WITH OBSTRUCTIVE FORM OF HYPERTROPHIC CARDIOMYOMATHY
View through CrossRef
Background. Hypertrophic cardiomyopathy (HCM) is the most common genetic cardiomyopathy. Extended septal myectomy ( ESM) is one of the priority methods of treatment of drug-refractory obstructive HCM. In recent years, hospital mortality during surgical correction of obstructive HCM in expert centers does not exceed 1–2 %. However, typical threatening complications of septal myectomy, such as iatrogenic ventricular septal defect (VSD) and rupture of the anterior or posterior walls of the left ventricle (LV), remain a topical issue in surgery of HCM. Objective: to show the role of preoperative CT-planning to predict and reduce possible technical problems associated with ESM, including iatrogenic VSD. Methods and materials. This study includes 217 symptomatic patients with obstructive HCM, who from April 2016 to October 2019 as one of the steps of preoperative planning underwent cardiac CT prior to ESM. Cardiac CT was performed to delineate the left ventricular myocardium, assess the distribution of hypertrophy and the presence of crypts. Special attention was also paid to the anatomy of the mitral valve (MV) and subvalvular apparatus. Coronary artery patency was assessed by CAD-RADS, a standardized method for reporting the results of coronary CT angiography to determine tactics for further management of the patient. Results and discussion. In the study group, the average age of patients was (49 ± 15) years, 48 % – men. All patients had a symptomatic, drug-refractory obstructive form of HCM. The mean maximum wall thickness of the interventricular septum (IVS) was (20 ± 5) mm (range 16–33). The average LV mass was (118 ± 23) g/m2. 195 patients (89.9 %) had systolic anterior motion ( SAM) of the MV. MV and subvalvular apparatus anomalies were detected in 62 patients (28.6 %). A zone of scarring and regression of IVS after alcohol septal ablation (ASA) was detected in 7 patients (0.3 %) with residual LV outflow gradient. Coronary arteries atherosclerosis was detected in 32 patients (14.7 %). Conclusions. Preoperative CT-planning of septal myectomy allows to obtain information on morphology of the LV, IVS, MV and subvalvular apparatus, and gives the surgeon the advantage to form a more accurate plan for the location and volume of septal resection, and avoid complications when correcting obstructive HCM. No iatrogenic VSD was detected in any of the patient in the study group. Key words: hypertrophic cardiomyopathy, computed tomography, preoperative planning, extended septal myectomy.
National Research Center for Radiation Medicine, Hematology and Oncology of the NAMS of Ukraine
Title: THE PLACE OF CARDIAC COMPUTED TOMOGRAPHY IN PREOPERATIVE PLANNING OF EXTENDED SEPTAL MYECTOMY IN PATIENTS WITH OBSTRUCTIVE FORM OF HYPERTROPHIC CARDIOMYOMATHY
Description:
Background.
Hypertrophic cardiomyopathy (HCM) is the most common genetic cardiomyopathy.
Extended septal myectomy ( ESM) is one of the priority methods of treatment of drug-refractory obstructive HCM.
In recent years, hospital mortality during surgical correction of obstructive HCM in expert centers does not exceed 1–2 %.
However, typical threatening complications of septal myectomy, such as iatrogenic ventricular septal defect (VSD) and rupture of the anterior or posterior walls of the left ventricle (LV), remain a topical issue in surgery of HCM.
Objective: to show the role of preoperative CT-planning to predict and reduce possible technical problems associated with ESM, including iatrogenic VSD.
Methods and materials.
This study includes 217 symptomatic patients with obstructive HCM, who from April 2016 to October 2019 as one of the steps of preoperative planning underwent cardiac CT prior to ESM.
Cardiac CT was performed to delineate the left ventricular myocardium, assess the distribution of hypertrophy and the presence of crypts.
Special attention was also paid to the anatomy of the mitral valve (MV) and subvalvular apparatus.
Coronary artery patency was assessed by CAD-RADS, a standardized method for reporting the results of coronary CT angiography to determine tactics for further management of the patient.
Results and discussion.
In the study group, the average age of patients was (49 ± 15) years, 48 % – men.
All patients had a symptomatic, drug-refractory obstructive form of HCM.
The mean maximum wall thickness of the interventricular septum (IVS) was (20 ± 5) mm (range 16–33).
The average LV mass was (118 ± 23) g/m2.
195 patients (89.
9 %) had systolic anterior motion ( SAM) of the MV.
MV and subvalvular apparatus anomalies were detected in 62 patients (28.
6 %).
A zone of scarring and regression of IVS after alcohol septal ablation (ASA) was detected in 7 patients (0.
3 %) with residual LV outflow gradient.
Coronary arteries atherosclerosis was detected in 32 patients (14.
7 %).
Conclusions.
Preoperative CT-planning of septal myectomy allows to obtain information on morphology of the LV, IVS, MV and subvalvular apparatus, and gives the surgeon the advantage to form a more accurate plan for the location and volume of septal resection, and avoid complications when correcting obstructive HCM.
No iatrogenic VSD was detected in any of the patient in the study group.
Key words: hypertrophic cardiomyopathy, computed tomography, preoperative planning, extended septal myectomy.
Related Results
Abstract 12214: Characterization of Iatrogenic Left Bundle Branch Block After Septal Myectomy for Hypertrophic Cardiomyopathy
Abstract 12214: Characterization of Iatrogenic Left Bundle Branch Block After Septal Myectomy for Hypertrophic Cardiomyopathy
Introduction:
LBBB results in impaired transseptal conduction and delayed posterolateral LV activation. Criteria for left bundle branch block (LBBB) vary across scienti...
Auditing the safety and efficacy of interventional septal reduction therapies in hypertrophic obstructive cardiomyopathy at a specialized tertiary centre
Auditing the safety and efficacy of interventional septal reduction therapies in hypertrophic obstructive cardiomyopathy at a specialized tertiary centre
Abstract
Funding Acknowledgements
Type of funding sources: None.
Background
...
Midterm Outcome of Septal Myectomy for Hypertrophic Obstructive Cardiomyopathy (HOCM): A Single-Center Observational Study
Midterm Outcome of Septal Myectomy for Hypertrophic Obstructive Cardiomyopathy (HOCM): A Single-Center Observational Study
Background: For years, septal myectomy has been considered the best available treatment for hypertrophic cardiomyopathy. In Bangladesh, however, this technique is only nascent. We ...
Abstract 17060: Effect of Septal Myectomy on Obstructive Sleep Apnea Syndrome in Patients With Hypertrophic Obstructive Cardiomyopathy
Abstract 17060: Effect of Septal Myectomy on Obstructive Sleep Apnea Syndrome in Patients With Hypertrophic Obstructive Cardiomyopathy
Introduction:
Hypertrophic cardiomyopathy (HCM) has a higher prevalence of OSA. The impact of obstructive sleep apnea on perioperative complications in hypertrophic obs...
Extended Myectomy for Apical Hypertrophic Cardiomyopathy: A Case Report
Extended Myectomy for Apical Hypertrophic Cardiomyopathy: A Case Report
Abstract
BackgroundApical hypertrophic cardiomyopathy is a variant of hypertrophic cardiomyopathy that predominantly affects the left ventricle apex and rarely involves the...
Clinical and Echocardiographic Determinants of Long-Term Survival After Surgical Myectomy in Obstructive Hypertrophic Cardiomyopathy
Clinical and Echocardiographic Determinants of Long-Term Survival After Surgical Myectomy in Obstructive Hypertrophic Cardiomyopathy
Background—
Surgical myectomy has been the standard treatment for patients with drug-refractory obstructive hypertrophic cardiomyopathy. The clinical and e...
Diagnostic capabilities of cardiac computed tomography in the preoperative diagnosis of hypertrophic cardiomyopathy
Diagnostic capabilities of cardiac computed tomography in the preoperative diagnosis of hypertrophic cardiomyopathy
BACKGROUND: A comprehensive approach to studying hypertrophic cardiomyopathy with diagnostic equipment and the latest scanning methods will ensure quality control and effective tre...
Clinical Outcomes of Concomitant Coronary Artery Bypass Grafting During Ventricular Septal Myectomy
Clinical Outcomes of Concomitant Coronary Artery Bypass Grafting During Ventricular Septal Myectomy
Background
The clinical characteristics and survival outcomes of patients who underwent concomitant coronary artery bypass grafting during septal myectomy have not been...

